Camilla Johansson

Employment

• Uppsala universitet Postdoctor
  2024 - Present
• KTH Royal Institute of Technology

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Cell painting and thermal proteome profiling for inference of drug targets and mechanism of action
  Molecular Systems Biology 2026 DOI: 10.1038/s44320-026-00214-9
  +Save
• Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS
  Skeletal Muscle 2025 DOI: 10.1186/s13395-025-00385-3
  +Save
• Integrating Cell Painting and Thermal Proteome Profiling for Inference of Targets and Mechanism of Action
  2025 DOI: 10.1101/2025.05.30.657006
  +Save
• Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers.
  Clinical proteomics 2023 DOI: 10.1186/s12014-023-09412-1
  +Save
• A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring
  Rachele Rossi, Camilla Johansson, Wendy Heywood +7 more
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms24065215
  +Save
• Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients
  Rachele Rossi, Maria Sofia Falzarano, Hana Osman +15 more
  Frontiers in Physiology 2021 DOI: 10.3389/fphys.2021.678974
  +Save
• Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
  Pharmacological Research 2020 DOI: 10.1016/j.phrs.2020.104999
  +Save
• Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
  Journal of Cachexia, Sarcopenia and Muscle 2020 DOI: 10.1002/jcsm.12517
  +Save